{"addison's disease": 9.29, "administration site extravasation": 2.87, "adrenal disorder": 39.21, "adrenal insufficiency": 58.15, "adrenocortical insufficiency acute": 16.07, "adrenocorticotropic hormone deficiency": 105.15, "adverse event": 15.49, "alanine aminotransferase abnormal": 3.12, "amylase increased": 4.76, "aortic arteriosclerosis": 2.98, "aortitis": 2.51, "ascites": 2.81, "aspartate aminotransferase abnormal": 4.9, "atelectasis": 3.13, "atrioventricular block complete": 2.47, "autoimmune arthritis": 32.58, "autoimmune colitis": 37.73, "autoimmune disorder": 2.25, "autoimmune haemolytic anaemia": 6.68, "autoimmune hepatitis": 14.86, "autoimmune hypothyroidism": 49.03, "autoimmune lung disease": 48.48, "autoimmune myocarditis": 72.12, "autoimmune myositis": 26.42, "autoimmune nephritis": 35.51, "autoimmune pancreatitis": 40.28, "autoimmune thyroiditis": 8.13, "bladder tamponade": 9.68, "blood albumin decreased": 2.69, "blood alkaline phosphatase abnormal": 6.74, "blood bilirubin abnormal": 3.54, "blood corticotrophin decreased": 34.3, "blood corticotrophin increased": 30.63, "blood creatinine abnormal": 3.71, "blood creatinine decreased": 2.77, "blood sodium decreased": 2.31, "blood thyroid stimulating hormone abnormal": 10.66, "blood thyroid stimulating hormone decreased": 10.36, "blood thyroid stimulating hormone increased": 15.11, "brain natriuretic peptide increased": 2.44, "brain oedema": 2.35, "c-reactive protein increased": 2.81, "cachexia": 2.0, "cancer pain": 11.65, "cancer surgery": 10.85, "capillary leak syndrome": 2.35, "carbohydrate antigen 125 increased": 3.37, "carcinoembryonic antigen increased": 4.79, "cardiac dysfunction": 4.1, "cardiac failure acute": 2.64, "cardiac tamponade": 9.39, "cardiomyopathy": 2.07, "central hypothyroidism": 5.94, "central venous catheterisation": 4.5, "chemotherapy": 6.03, "cholangitis": 13.23, "cholangitis sclerosing": 68.09, "cholecystitis": 5.83, "cholecystitis acute": 5.37, "cholestatic liver injury": 2.28, "chronic gastritis": 2.43, "colitis": 16.63, "colitis microscopic": 4.55, "coronavirus infection": 2.95, "cortisol abnormal": 24.73, "cortisol decreased": 19.22, "cortisol increased": 7.82, "cutaneous sarcoidosis": 5.83, "cutaneous symptom": 4.13, "cytokine release syndrome": 2.07, "cytokine storm": 12.56, "cytomegalovirus enterocolitis": 6.18, "cytopenia": 2.33, "death": 3.14, "decreased appetite": 2.52, "demyelinating polyneuropathy": 2.34, "dermatitis": 2.27, "dermatitis psoriasiform": 8.15, "dermatomyositis": 8.56, "device related infection": 2.2, "diabetes mellitus": 2.32, "diabetic ketoacidosis": 4.19, "disseminated intravascular coagulation": 3.66, "drug effective for unapproved indication": 4.08, "drug eruption": 2.92, "drug-induced liver injury": 2.94, "duodenal perforation": 6.97, "duodenal ulcer": 2.48, "duodenitis": 3.0, "dysphonia": 3.72, "eastern cooperative oncology group performance status worsened": 64.94, "electrolyte imbalance": 2.42, "emphysema": 2.02, "encephalitis": 10.58, "encephalitis autoimmune": 19.02, "endocrine disorder": 10.61, "enteritis": 4.74, "enteritis infectious": 3.99, "enterocolitis": 16.28, "enterocolitis haemorrhagic": 2.26, "eosinophil count increased": 3.86, "eosinophil percentage increased": 7.33, "eosinophilic fasciitis": 14.42, "erythema multiforme": 4.5, "eyelid ptosis": 7.07, "febrile bone marrow aplasia": 3.45, "febrile neutropenia": 2.6, "feeding disorder": 2.51, "female genital tract fistula": 14.72, "fistula": 4.15, "fulmit type 1 diabetes mellitus": 122.74, "gallbladder enlargement": 2.91, "gastric perforation": 2.61, "gastrointestinal oedema": 4.09, "gastrointestinal perforation": 8.76, "general physical health deterioration": 2.1, "glomerulonephritis membranous": 3.12, "glomerulonephritis rapidly progressive": 4.69, "glucocorticoid deficiency": 27.06, "guillain-barre syndrome": 2.71, "haemoglobin abnormal": 4.1, "haemophagocytic lymphohistiocytosis": 8.51, "hepatic cyst": 2.0, "hepatic cytolysis": 2.7, "hepatic failure": 2.02, "hepatic function abnormal": 4.84, "hepatitis": 7.41, "hepatitis fulmit": 2.68, "hepatotoxicity": 2.56, "hospice care": 11.06, "hydronephrosis": 4.39, "hyperamylasaemia": 4.65, "hypercalcaemia": 2.26, "hyperlipasaemia": 3.83, "hypertension": 3.81, "hyperthyroidism": 17.61, "hypertransaminasaemia": 2.46, "hypoalbuminaemia": 3.46, "hypophysitis": 38.06, "hypopituitarism": 52.68, "hypothalamo-pituitary disorder": 35.25, "hypothyroidism": 37.06, "ileus": 3.39, "ill-defined disorder": 3.06, "immune thrombocytopenia": 5.06, "immune-mediated adrenal insufficiency": 263.38, "immune-mediated adverse reaction": 105.25, "immune-mediated arthritis": 131.92, "immune-mediated cholangitis": 312.99, "immune-mediated cystitis": 68.87, "immune-mediated dermatitis": 84.66, "immune-mediated encephalitis": 98.95, "immune-mediated endocrinopathy": 94.77, "immune-mediated enterocolitis": 133.35, "immune-mediated gastritis": 103.0, "immune-mediated hepatic disorder": 199.27, "immune-mediated hepatitis": 78.49, "immune-mediated hyperthyroidism": 323.03, "immune-mediated hypophysitis": 38.35, "immune-mediated hypothyroidism": 416.93, "immune-mediated lung disease": 92.48, "immune-mediated myasthenia gravis": 158.69, "immune-mediated myocarditis": 101.73, "immune-mediated myositis": 77.48, "immune-mediated nephritis": 80.38, "immune-mediated neurological disorder": 74.07, "immune-mediated neuropathy": 36.58, "immune-mediated pancreatitis": 158.48, "immune-mediated pancytopenia": 71.32, "immune-mediated pericarditis": 99.42, "immune-mediated renal disorder": 241.88, "immune-mediated thyroiditis": 58.7, "immune-mediated uveitis": 128.02, "inability to afford medication": 2.2, "inappropriate antidiuretic hormone secretion": 2.16, "inappropriate schedule of product administration": 3.22, "infectious pleural effusion": 5.92, "infusion related reaction": 2.87, "interstitial lung disease": 21.6, "intestinal fistula": 8.81, "intestinal perforation": 4.86, "intra-abdominal fluid collection": 3.83, "kl-6 increased": 26.3, "large intestine perforation": 4.2, "leukoderma": 23.6, "lichen planus": 8.46, "lichenoid keratosis": 13.41, "lipase increased": 2.37, "liver abscess": 2.35, "liver disorder": 3.69, "lung abscess": 4.09, "lung carcinoma cell type unspecified recurrent": 6.74, "lung consolidation": 2.73, "lung disorder": 4.17, "lung opacity": 8.61, "lymphadenectomy": 12.1, "lymphadenopathy mediastinal": 4.97, "lymphangiosis carcinomatosa": 21.34, "lymphocytic hypophysitis": 17.75, "maligt ascites": 17.3, "maligt neoplasm progression": 37.39, "maligt pleural effusion": 18.24, "mastectomy": 3.98, "melanoma recurrent": 27.06, "meningitis": 4.5, "meningitis aseptic": 2.23, "metastases to meninges": 3.81, "metastatic maligt melanoma": 2.86, "mixed liver injury": 2.27, "mucosal inflammation": 2.92, "myasthenia gravis": 28.38, "myasthenia gravis crisis": 8.33, "myasthenic syndrome": 17.78, "myocardial necrosis marker increased": 2.68, "myocarditis": 5.49, "myositis": 20.59, "nephritis": 34.42, "nephrotic syndrome": 3.0, "neuromyopathy": 2.72, "neuropathy peripheral": 2.61, "neutrophil count decreased": 2.97, "non-small cell lung cancer recurrent": 21.67, "nutritional condition abnormal": 6.22, "ocular myasthenia": 11.47, "oesophageal stenosis": 3.24, "onychomadesis": 2.16, "ophthalmoplegia": 2.83, "optic neuritis": 3.35, "oral mucosa erosion": 3.39, "organising pneumonia": 15.69, "oxygen saturation abnormal": 2.86, "oxygen therapy": 4.68, "palliative care": 7.53, "palmar-plantar erythrodysaesthesia syndrome": 11.27, "pancreatic enzymes increased": 2.41, "pancreatic failure": 4.49, "paraneoplastic syndrome": 12.68, "pemphigoid": 13.91, "pericardial effusion": 3.51, "pericarditis maligt": 94.21, "physical deconditioning": 3.07, "platelet count decreased": 4.32, "pleural effusion": 3.8, "pneumatosis intestinalis": 3.83, "pneumocystis jirovecii pneumonia": 4.14, "pneumonia": 2.33, "pneumonia aspiration": 3.61, "pneumonia bacterial": 9.65, "pneumonitis": 22.78, "pneumothorax": 4.39, "polyarthritis": 6.88, "polymyalgia rheumatica": 6.19, "polymyositis": 9.52, "posterior reversible encephalopathy syndrome": 2.38, "postrenal failure": 9.85, "prerenal failure": 4.99, "primary adrenal insufficiency": 22.2, "primary hypothyroidism": 14.42, "procalcitonin increased": 3.97, "product use in unapproved indication": 6.98, "product use issue": 3.73, "protein urine": 14.92, "protein urine present": 3.6, "proteinuria": 14.45, "pulmonary mass": 2.09, "pulmonary sarcoidosis": 8.75, "pulmonary toxicity": 10.62, "pulmonary tuberculosis": 2.26, "pyelonephritis": 2.75, "radiation pneumonitis": 30.72, "radiotherapy": 20.07, "recurrent cancer": 9.28, "red blood cell transfusion": 4.53, "renal disorder": 2.0, "renal impairment": 3.67, "renal tubular acidosis": 2.92, "respiratory failure": 2.22, "retroperitoneal fibrosis": 4.59, "rheumatic disorder": 2.02, "salivary hyposecretion": 3.48, "sarcoidosis": 5.23, "scleroderma": 2.14, "secondary adrenocortical insufficiency": 36.62, "septic shock": 2.64, "seronegative arthritis": 5.71, "sialoadenitis": 5.79, "silent thyroiditis": 56.43, "sjogren's syndrome": 7.08, "skin disorder": 4.04, "skin erosion": 2.09, "skin toxicity": 8.34, "small intestinal haemorrhage": 2.89, "small intestinal perforation": 17.94, "stevens-johnson syndrome": 4.16, "stomatitis": 4.81, "stress cardiomyopathy": 2.88, "superior vena cava syndrome": 6.02, "systemic inflammatory response syndrome": 2.14, "terminal state": 2.03, "therapeutic response increased": 2.52, "therapy partial responder": 17.59, "thrombophlebitis migrans": 41.66, "thyroid disorder": 12.71, "thyroid function test abnormal": 6.67, "thyroid hormones decreased": 11.78, "thyroid hormones increased": 8.85, "thyroiditis": 41.19, "thyroiditis subacute": 2.32, "thyrotoxic crisis": 8.89, "thyroxine free decreased": 5.31, "thyroxine free increased": 6.28, "toxic epidermal necrolysis": 3.82, "transfusion": 2.65, "tri-iodothyronine free decreased": 13.82, "tri-iodothyronine free increased": 16.13, "troponin i increased": 2.84, "troponin increased": 4.74, "troponin t increased": 3.71, "tubulointerstitial nephritis": 11.29, "tumour associated fever": 58.86, "tumour haemorrhage": 7.48, "tumour hyperprogression": 95.76, "tumour lysis syndrome": 2.95, "tumour marker increased": 4.33, "tumour necrosis": 17.31, "tumour pain": 7.91, "tumour pseudoprogression": 81.05, "type 1 diabetes mellitus": 38.05, "type 2 diabetes mellitus": 2.01, "uveitis": 4.46, "vitiligo": 22.12, "vocal cord paralysis": 2.08, "vogt-koyanagi-harada disease": 10.24, "warm autoimmune haemolytic anaemia": 12.17}